EUVIMEDEUVIMED entdecken
Kohortenstudie

Early Use of 25% Albumin in Sepsis Resuscitation Is Not Associated with Worsened Renal Outcomes: A Propensity-Matched Retrospective Cohort Study of MIMIC-IV

Christian Josef Wiedermann

Eurasian Journal of Critical Care · 10.08.2026 · 8 (2) · 61-69

DOI: 10.55994/ejcc.1973848 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Eurasian Journal of Critical Care, online erschienen am 10.08.2026. Verfasst von Christian Josef Wiedermann. Die Arbeit nennt 41 Literaturangaben. Gefördert von: None — this research received no specific grant or financial support from any funding agency in the public, commercial, or not-for-profit sectors..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The use of hyperoncotic (25%) albumin in sepsis resuscitation remains controversial because of concerns about nephrotoxicity, particularly in patients with pre-existing renal impairment. This study examined whether early administration of 25% albumin in addition to crystalloids increases the risk of acute kidney injury or worsens short-term hemodynamic outcomes compared with crystalloids alone.Materials and Methods: A retrospective cohort study was performed using a large, publicly available intensive care database. Adult patients with sepsis who received crystalloids alone or crystalloids plus 25% albumin within the first 24 hours of intensive care admission were identified; patients receiving 5% albumin were excluded. Propensity score matching (1:1) was applied using demographics, laboratory values, organ-dysfunction sub-scores, and comorbidities. The primary outcome was acute kidney injury, defined by standardized consensus criteria. Secondary outcomes were renal replacement therapy, intensive care length of stay, and vasopressor-free days.

Results

Among 15,882 patients, 587 matched pairs were analyzed. The incidence of acute kidney injury was similar between groups (albumin, 60.3% versus control, 56.2%; p = 0.174), as was the need for renal replacement therapy (23.9% versus 27.8%; p = 0.142). Intensive care length of stay and vasopressor-free days did not differ. Despite higher lactate levels and greater hepatic and coagulation dysfunction in the albumin group, renal sub-scores and comorbidities were comparable.

Conclusion

Early administration of 25% albumin with crystalloids was not associated with worse short-term renal or hemodynamic outcomes. These findings support clinical equipoise and suggest that cautious use of 25% albumin in selected patients confers no additional renal risk.

Förderung

  • None — this research received no specific grant or financial support from any funding agency in the public, commercial, or not-for-profit sectors.

Zitieren

APA

Wiedermann, C. J. (2026). Early Use of 25% Albumin in Sepsis Resuscitation Is Not Associated with Worsened Renal Outcomes: A Propensity-Matched Retrospective Cohort Study of MIMIC-IV. Eurasian Journal of Critical Care, 8(2), 61-69. https://doi.org/10.55994/ejcc.1973848

Vancouver

Wiedermann CJ. Early Use of 25% Albumin in Sepsis Resuscitation Is Not Associated with Worsened Renal Outcomes: A Propensity-Matched Retrospective Cohort Study of MIMIC-IV. Eurasian Journal of Critical Care. 2026;8(2):61-69. doi:10.55994/ejcc.1973848

BibTeX
@article{Wiedermann2026,
  author = {Wiedermann, Christian Josef},
  title = {Early Use of 25% Albumin in Sepsis Resuscitation Is Not Associated with Worsened Renal Outcomes: A Propensity-Matched Retrospective Cohort Study of MIMIC-IV},
  journal = {Eurasian Journal of Critical Care},
  year = {2026},
  volume = {8},
  number = {2},
  pages = {61--69},
  doi = {10.55994/ejcc.1973848}
}
Kostenlos starten →